Skip to main content
Journal cover image

P1627 Does infarct size measured by creatine kinase-MB predict clinical outcomes after fibrinolysis and primary percutaneous coronary intervention?

Publication ,  Conference
MAHAFFEY, K
Published in: European Heart Journal
March 2003

Duke Scholars

Published In

European Heart Journal

DOI

ISSN

0195-668X

Publication Date

March 2003

Volume

24

Issue

5

Start / End Page

301 / 301

Publisher

Elsevier BV

Related Subject Headings

  • Cardiovascular System & Hematology
  • 3202 Clinical sciences
  • 3201 Cardiovascular medicine and haematology
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
MAHAFFEY, K. (2003). P1627 Does infarct size measured by creatine kinase-MB predict clinical outcomes after fibrinolysis and primary percutaneous coronary intervention? In European Heart Journal (Vol. 24, pp. 301–301). Elsevier BV. https://doi.org/10.1016/s0195-668x(03)94765-8
MAHAFFEY, K. “P1627 Does infarct size measured by creatine kinase-MB predict clinical outcomes after fibrinolysis and primary percutaneous coronary intervention?” In European Heart Journal, 24:301–301. Elsevier BV, 2003. https://doi.org/10.1016/s0195-668x(03)94765-8.
MAHAFFEY, K. “P1627 Does infarct size measured by creatine kinase-MB predict clinical outcomes after fibrinolysis and primary percutaneous coronary intervention?European Heart Journal, vol. 24, no. 5, Elsevier BV, 2003, pp. 301–301. Crossref, doi:10.1016/s0195-668x(03)94765-8.
Journal cover image

Published In

European Heart Journal

DOI

ISSN

0195-668X

Publication Date

March 2003

Volume

24

Issue

5

Start / End Page

301 / 301

Publisher

Elsevier BV

Related Subject Headings

  • Cardiovascular System & Hematology
  • 3202 Clinical sciences
  • 3201 Cardiovascular medicine and haematology
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology